◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
Condition Breast Cancer
Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2018-01-01
Completion 2023-12
All Conditions
Interventions
Endocrine therapy
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Little is known about the correlation between ultrasound characteristics (conventional, elastography and contrast enhanced ultrasound (CEUS) )and pathological prognostic factors in breast cancer. The aim of this study was to explore the correlation between ultrasound characteristics and pathological prognostic factors using radiomics.
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of breast cancer Exclusion Criteria: Missing pathology Missing follow-up results Missing data
Related Trials
NCT05206331
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
View Trial →
NCT06566937
The Effectiveness of E-health Intervention in Improving Mental Health Outcomes Among Breast Cancer P
View Trial →
NCT02290834
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology